Erectile dysfunction and depression drugs recalled after factory ‘mix up’
Mix up was a result of third-party error, says drug-maker
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.A Tennessee-based pharmaceutical company is recalling two drugs that got "mixed up" while being packaged in a factory.
AvKARE said on Wednesday its 100mg Sidenafil and 100mg Trazodone tablets were put in the same bottles due to a "third party" error.
Sidenafil is the main ingredient in Viagra, a medication used to treat erectile dysfunction, while Trazodone is used to treat depression.
Sidenafil may pose serious health risks to consumers with underlying medical issues and others who are not supposed to take it, AvKARE said in a statment.
Trazodone may result in adverse health consequences such as sedation, dizziness, constipation, and blurred vision, the company added.
AvKARE said it had not yet recieved any reports of people getting sick as a result of taking the wrong medication.
In a statement published on the US Food and Drug Administration's website, the company said it is recalling one batch of both products.
Those affected are Sildenafil 100 mg tablet lot 36884 with an expiration date of 03/2022, and Trazodone Hydrochloride 100 mg tablet lot 36783 with an expiration date of 06/2022.
AvKARE said the drugs were "distributed to our distributors and wholesalers, and then further distributed nationwide".
The company “notified its distributors and customers and is arranging for return of all recalled product of the listed lots”.
Anyone who has an adverse reaction to taking either drug by mistake is being asked to contact the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments